中药临床再评价的特殊性(2)

http://www.100md.com 2014年1月1日 《中国中药杂志》 2014年第1期

     [参考文献]

    [1] 何伟，谢雁鸣，王永炎.中药上市后临床再评价研究若干问题思考[J].中国中药杂志，2010，35(12)：1641.

    [2] 何伟，谢雁鸣，王永炎.中药上市后临床再评价应关注证候再评价[J].中国中药杂志，2010，35(11)：1498.

    [3] 何伟，谢雁鸣.中药上市后证候临床再评价模式探索[J].中医杂志，2012，53(4)：297.

    Specificity of traditional Chinese medicine′s clinical re-evaluation

    LI Lian-da， LI Yi-kui， LI Feng-jie

    (Xiyuan Hospital， China Academy of Chinese Medical Sciences， Beijing 100091， China)

    [Abstract] Clinical re-evaluation is to verify the drug′s safety and effectiveness again，while the drug itself has not been improved. However， due to the complexity of traditional Chinese medicine， ingredients in bulk drugs， prescription， productive processes， quality standards and other aspects need to be enhanced. So improving the quality， safety and effectiveness of traditional Chinese medicine by clinical re-evaluation is also very necessary. Therefore， except for achieving those basic requirements of medicine， it should also be improved on itself and pay full attention to the particularity， then traditional Chinese medicine′s clinical re-evaluation will play its due role.

    [Key words] Chinese medicine； clinical re-evaluation； improve； enhance

    doi：10.4268/cjcmm20140101

    [责任编辑 陈玲](李连达 李贻奎 李峰杰)

上一页 第 1 2 页

    百拇医药网 http://www.100md.com/html/paper/1001-5302/2014/01/01-1.htm